Skip to main content
. 2021 May 12;12(5):e00356. doi: 10.14309/ctg.0000000000000356

Table 3.

Clinical factors with high expression of serum miR-1290

High expression of serum miR-1290 (n = 13) Univariatea
P value
Multivariateb
OR (95% CI) P value
Age, n (%)
 <70 yr 6/13 (46.1) 1.00
 ≥70 yr 7/13 (53.8)
Sex, n (%)
 Male 5/10 (50.0) 1.00
 Female 8/16 (50.0)
Location, n (%)
 Right colon 7/19 (36.8) 0.07 Reference
 Left colon 6/7 (85.7) 5.59 (0.26–118.23) 0.27
Macroscopic type, n (%)
 Protruding 1/3 (33.3) 0.14 Reference
 LST-G 10/15 (66.7) 15.6 (0.34–710.67) 0.16
 LST-NG 2/8 (25.0) 11.3 (0.15–829.61) 0.27
Tumor size, n (%)
 <12.6 cm2 11/13 (84.6) <0.01 Reference
 ≥12.6 cm2 2/13 (15.4) 33.1 (1.97–556.64) 0.02
Vienna Classification, n (%)
 Category 3 6/14 (42.9) 0.70
 Category 4 7/12 (58.3)

Factors with P value of less than 0.2 in univariate analysis were included in multivariate analyses.

CI, confidence interval; LST-G, laterally spreading tumor granular type; LST-NG, laterally spreading tumor nongranular type; OR, odds ratio.

a

Chi-square test or Fisher's exact probability test.

b

Multiple logistic regression analysis.